Aqueous Multiphase System for Mammalian Cell Separation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for separating cultured mammalian cells from contaminants in cell cultures, such as bacteria and nonviable cells, often require antibiotics that can interfere with cell processes and result in the disposal of valuable cell populations, which is inefficient and wasteful.

Innovation Solution

A density-based method using an aqueous multiphase system (AMPS) with a polyethylene glycol (PEG)-Ficoll system, where the physical properties are tuned to separate mammalian cells from contaminants based on their respective densities, allowing cells to be recovered from the liquid-liquid interface while contaminants sediment at the bottom of the container.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotics are used to treat or prevent contamination, then contamination is controlled, but cell processes are interfered with and antibiotic resistance develops

Engineering Contradiction:
Improvecontamination controlVSAvoidantibiotic interference with cell processes
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes contaminants from the cell culture using density-based centrifugal separation. Contaminants are separated from viable cells based on density differences, allowing selective removal of harmful elements without affecting the cells, thereby eliminating the need for antibiotics that would interfere with cell processes.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces an aqueous multiphase system as an intermediary medium between the cell culture and the separation process. This intermediary system enables selective separation of contaminants from cells through density gradients, providing a alternative to direct antibiotic treatment that avoids harmful effects on cell processes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If contaminated cultures are destroyed with bleach, then contaminants are eliminated, but valuable cell populations are disposed of

Engineering Contradiction:
Improvecontaminant eliminationVSAvoidloss of valuable cell populations
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent extracts and removes only the contaminants from the cell culture through density-based centrifugal separation. By separating contaminants from viable cells based on density differences, the method eliminates contaminants while preserving and recovering valuable cell populations, avoiding their disposal.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent implements a process to discard contaminants while recovering viable cells. Through density-based separation, contaminants are discarded at the bottom of the centrifuge tube while viable cells are recovered from the interface region, enabling reuse of valuable cell populations that would otherwise be lost.

Inventive Principle:
Principle #34Discarding and recovering

3Reliability

If density-based separation is used, then cells and contaminants are separated effectively, but the system complexity increases

Engineering Contradiction:
Improveseparation effectivenessVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent utilizes changes in density as a key parameter to achieve separation. By adjusting the density characteristics of the aqueous multiphase system, viable cells and contaminants are separated based on their inherent density differences. This parameter-based approach provides effective separation using a relatively simple centrifugal process rather than complex multi-step systems.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively enriches viable cell populations, reduces the need for antibiotics, and preserves the viability and growth rates of recovered cells, enabling the reuse of cultures that would otherwise be discarded.

Implementation Method 1

The top liquid phase has a top liquid density that is different than a bottom liquid density of the bottom liquid phase... In response to the centrifuging and in accordance with the respective density, the cultured mammalian cells are separated from the contaminants

Methodology Applied
Scientific EffectDensity gradient separation: Density Gradient

Implementation Method 2

The container, containing the liquid and the cover medium, is, then, centrifuged for a second time period subsequent to the first time period

Methodology Applied
Scientific EffectCentrifugation: Centrifuge

Implementation Method 3

The container, containing the liquid and the cover medium, is, then, centrifuged for a second time period... In response to the centrifuging and in accordance with the respective density

Methodology Applied
Scientific EffectCentrifugal force: Centrifugal Force

Data Source

PatentUS12115471B2Aqueous two-phase system for the separation and recovery of mammalian cells from contaminated cultures
Publication Date: 2024.10.15 TRUSTEES OF TUFTS COLLEGE
  • US12115471B2 patent drawing
  • US12115471B2 patent drawing
  • US12115471B2 patent drawing

AI summary

A method is directed to separating contaminants from mammalian cells in an aqueous multiphase system, and includes loading a container with a liquid having a top liquid phase and a bottom liquid phase. A cover medium is inserted in the container with a mixture of cultured mammalian cells and contaminants. The container is incubated and centrifuged for respective periods of time. In response to the centrifuging, the cells are separated from the contaminants in accordance with the respective density of the cells, the contaminants, and each liquid phase, resulting in the cells being located at a liquid-to-liquid interface between the top liquid phase and the bottom liquid phase and the contaminants being located at the bottom of the container.